2026 International Congress » Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Meeting: 2026 International Congress

5-year Longitudinal Changes in Non-motor Symptoms and Their Association With Motor Progression in Parkinson’s Disease

S. Heinzel, Q. Destani-Dauti, M. Hobert, W. Maetzler, D. Berg (Kiel, Germany)

A Brief Clinical Test Battery Predicting UPDRS II Disability in Parkinson Disease

R. Dias, G. Santos, P. Silva, M. Pimentel Piemonte (São Paulo, Brazil)

A Large-Scale Digital Parkinson Disease Platform Matches Clinician Identification of Dyskinesia and Uncovers Unmet Need Between Visits

A. Hare, B. Hood, S. Shaffer, R. Gilron (San Francisco, USA)

A Novel Clinical Protocol for Monitoring Therapeutic Outcomes in Camptocormia in Parkinson´s Disease

L. Lundh, E. Franzén, S. Grigoriou, M. Söderholm, W. Duzynski, F. Strömqvist, B. Lindholm (Ängelholm, Sweden)

A Patient-Directed AI-Enabled Platform for Continuous Personalised Parkinson’s Management

E. Meinert, J. Schivers, A. Ananthakrishnan, C. Carroll (Newcastle, United Kingdom)

Acceptability and feasibility of digital mobility assessment for Parkinson’s Disease: Perspectives from people with Parkinson’s, carers and health and social care professionals in Ghana and Kenya

R. Mc Ardle, J. Lumsdon, B. Mghendi, E. Ame-Bruce, W. Animdife, M. Agoriwo, M. Cham, A. Akpalu, S. Del Din, L. Rochester, K. Brittain, R. Walker, N. Fothergill-Misbah (Newcastle upon Tyne, United Kingdom)

Additive effect of Diabetes Mellitus and genetic risk variant in Parkinson’s Disease

B. Tan, S. Chan, L. Chan, L. Tan, E. Tan (Singapore, Singapore)

Age-Modulated Gait Adaptations to Progressive Fatigue in Parkinson’s Disease

T. Bowman, D. Anastasi, C. Agliardi, P. Arcuri, F. Baglio, E. Calabrese, A. Castagna, M. Clerici, A. Crippa, E. Farina, S. Gobbo, FR. Guerini, F. La Rosa, M. Alberoni, C. Pagliari, A. Salvatore, M. Saresella, FL. Saibene, M. Meloni, D. Cattaneo (Varese, Italy)

Antimicrobial Use and Risk of Parkinson’s Disease: A Swedish National Case-control Study

S. Licaj, A. Ploner, M. Szilcz, J. Wastesson, S. Hägg, F. Fang, K. Wirdefeldt (Solna, Sweden)

Apparent Change Classification with Stage-Specific and Fixed Minimal Detectable Change Thresholds in Parkinson’s Disease

R. Yamasaki, Y. Inoue (Kurashiki, Okayama, Japan)

Are we overlooking wearing off? Evaluating the role of the WOQ-9 questionnaire in routine Parkinson’s care

G. Heery, B. Mohamed, J. Adenwalla (Cardiff, United Kingdom)

Assessment of Demographic and Clinical Characteristics of Early- and Late-Onset Parkinson’s Disease in Bangladesh.

T. Zannat, K. Dey, A. Haque, A. Zirra, E. Camboe, D. Mair, S. Waters, S. Ali, C. Marshall, N. Mukadam, R. Weil, A. Noyce, A. Habib (Dhaka, Bangladesh, Bangladesh)

Assessment of Postural abnormalities in Early-stage Parkinson’s Disease Using a Posture Analyzing and Virtual Reconstruction Device

HW. Yang, SI. Choi, WH. Lee, NY. Kim (Yongin, Republic of Korea)

Association Between Liver Function and Motor Symptoms in Parkinson’s Disease: A Cross-cohort Analysis of Chinese and PPMI patients

Y. Wang, X. Zheng, X. Liu, C. Li (Chengdu, China)

Association between probable RBD and reduced CSF 5-hydroxyindoleacetic acid levels in Parkinson’s disease

K. Hatano, M. Kameyama, M. Kurihara, A. Iwata (Tokyo, Japan)

Association between Sleep Behaviors and Age at Onset of Parkinson’s Disease

N. Zhou, M. Fang, L. He, T. Shao, Z. Liu, B. Liu, R. Li, W. Li (Beijing, China)

Association Between Step Count Change Rate During Dual Task Timed Up and Go and Balance Components in Parkinson’s Disease

Y. Yamazaki, T. Nakamura, K. Watanabe, G. Horiguchi, S. Kishimoto, H. Miyamoto, Y. Kameyama, E. Kitahara, K. Haruyama, N. Nishikawa, T. Hatano, N. Hattori, T. Fujiwara (Bunkyo-ku, Japan)

Association Between the Side of Tremor Onset and Clinical Profiles of Patients with Parkinson’s disease in Rural and Urban Tanzania

K. Okeng'O, W. Walker, N. Okubadejo, P. Adebayo, N. Fothergill-Misbah, M. Dekker, B. Mushengezi, G. Lyimo, E. Massawe, M. Mng'Ong'O, J. Silvester, S. Urasa (Dar es salaam, United Republic of Tanzania)

Association of Benign Prostatic Hyperplasia With Incident Parkinson’s Disease in Men: A Prospective Cohort Study From the UK Biobank

Y. Yu, X. Zheng, Y. Wang, X. Liu, H. Shang, C. Li (Chengdu, China)

Association of IL-6 and Lp(a) with Incidental Parkinson’s Disease Risk and Motor Severity After Stroke: A Prospective Cohort Study

Z. Zhu, H. Wang, Y. Geng, Z. Yin, Y. Xu, M. Xu, J. Shi, Y. Yuan, K. Yi, D. Geng, K. Zhang (Nanjing, China)

Association of Sarcopenia with Fear of Falling and Falls in patients with Parkinson’s disease

I. Dagklis, D. Kazis, S. Bostantjopoulou (Thessaloniki, Greece)

Bidirectional Association Between Gout and Parkinson’s Disease: A Systematic Review and Meta-Analysis

V. Byroju, J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)

Burden and Geographic Distribution of Parkinson’s Disease in Mexico: A GBD 2021 Analysis (1990-2023)

K. Farias-Moreno, KC. Carrazco-Peña, E. Gómez-Figueroa, CZ. Zúñiga-Ramírez (Guadalajara, Mexico)

Can Prayer Beads Quantify Bradykinesia? An Ultra-Low-Cost Approach to Motor Assessment in Parkinson’s Disease

N. Raisa, B. Perwirayuda, SB. Rianawati, AC. Pratiwi (Malang, Indonesia)

Causes of Death and Clinical Predictors of Mortality in Parkinson’s Disease and Parkinsonism: A 30-Year Population-Based Study

F. Onorati, L. Malfer, A. Mullan, R. Savica (Rome, Italy)

Challenges of Translating the MDS-UPDRS into Ukrainian During Wartime

TV. Voloshyn, IP. Popovych, NM. Melekh, OK. Kachmar (TRUSKAVETS, Ukraine)

Changes in ADL-Related Factors According to Disease Stage in Patients with Parkinson’s Disease: Multiple Regression Analysis

K. Watanabe, T. Nakamura, G. Horiguchi, H. Miyamoto, Y. Yamazaki, Y. Kameyama, E. Kitahara, K. Haruyama, N. Nishikawa, T. Hatano, N. Hattori, T. Fujiwara (Bunkyo-ku, Japan)

Characteristics and Outcomes of Hospitalisation Episodes for Australians living with Parkinson’s Disease

S-E. Soh, M. Callisaya, V. Mcconvey, K. Bower, A. Terrens, M. Klaic, A. Vogel, J. Mcginley (Melbourne, Australia)

Characteristics And Progression Of Non-Motor Symptoms In Parkinsons Disease

A. Shalash, M. Salama, M. Essam, Y. Mahran, E. Hamid, A. Helmy (Cairo, Egypt)

Characteristics of participants of the Australian National Disability Insurance Scheme with Parkinson’s disease

J. Mcginley, K. Bower, V. Mcconvey, M. Callisaya, A. Khan, M. Ho, D. Shen, S. Fernando, M. Klaic, S. Soh (Parkville, Australia)

Characterizing Gastrointestinal Dysfunction and its Psychosocial Associations in Idiopathic Parkinson’s Disease: Findings from a Single centre Prospective Cross-sectional Indian study

A. Janardhan, A. Mehta, P. Hiremath, P. R, L. R, M. Javali, P. Acharya (Bengaluru, India)

Characterizing Longitudinal Motor Progression in Parkinson’s Disease leveraging Digital Health Technologies in L-DOPA ON and OFF States

S. Lambrecht, Y. Gazizova, F. Lipsmeier, W. Popp, B. Fehlmann, T. Nikolcheva, N. Pross, M. Lindemann, K. Taylor (Basel, Switzerland)

Clinical and Biomarker Trajectories in GBA1 Non-Manifesting Carriers With and Without α-Synuclein Seed Amplification Positivity

P. Gonzalez-Latapi, S. Brooker, C. Gochanour, M. Brumm, K. Merchant, R. Alcalay, T. Simuni (Chicago, USA)

Clinical and Sociodemographic Characteristics of Rural and Urban Individuals Living with Parkinson’s Disease

K. Dyer, D. Shah-Zamora (Winston Salem, USA)

Clinical Characteristics of Fracture Injury by Falling in Parkinson’s Disease, a Prospective Cohort Study

J. Lee (Seongnam-si, Republic of Korea)

Clinical Characteristics of Gastric Motility Disorder in Early-Stage Parkinson’s Disease and Its Longitudinal Predictive Value for Disease Progression

X-Y. Cheng, J-Y. Jin, C-J. Mao, C-F. Liu (Suzhou, China)

Clinical Factors Associated with the Hospitalization of Patients with Parkinson’s Disease: A 3-year Prospective Study

R. Morimoto, K. Todo, M. Iijima (Tokyo, Japan)

Clinical Gait Traits and Cerebellar-PPN Functional Connectivity Abnormalities in Early and Moderate-to-Advanced PD with Gait Disturbance via Perceptual Technology and MRI

J. Su, D. Liu, J. Shang, L. She, H. Wang, Y. Pan (Wuhan, China)

Clinical instability and fluctuations as an early marker of accelerated progression

A. Beltrán-Torres, M. Rocha-de-León, K. Sánchez-Ramírez, N. Sánchez-Lorenzo, A. Cervantes-Arriaga, M. Rodríguez-Violante (Monterrey, Mexico)

Clinical Outcome Assessments for Parkinson’s Disease Psychosis: A Systematic Review

E. Camboe, S. Delray, MHS. Tosin, AJ. Noyce, C. Cooper (London, United Kingdom)

Clinical Profile of Early-Onset Parkinson’s Disease in a Tertiary Hospital in Oman

J. Al Balushi, AL. Aldarmaki, R. Al Bahlani, AZ. Al Makhmari, AH. Al Qassabi (Muscat, Oman)

Clinical Stage According to Hoehn & Yahr Scale as a Predictor of Non-Motor Symptom Severity in Parkinson’s Disease: A Cross-Sectional in Peru

J. Moya-Salazar, A. Sobrino-Galindo, B. Cañari (Chiclayo, Peru)

Comorbid Diabetes Exacerbates Motor and Nonmotor Dysfunction in Parkinson’s disease- a Cross-sectional Study

S. Krishnan, S. Veena, A. Vijayaraghavan, S. Sachithanandan, D. Puthenveedu (Thiruvananthapuram, India)

Considering Oral Health to Optimise the Potential for Current and Future Treatments in Parkinson’s Disease

J. Price, H. Martin (Powys, United Kingdom)

Continuous Subcutaneous Apomorphine Infusion in Parkinson Disease: Final Data from the Multi-Year InfusON Open-Label Extension Study

P. Lewitt, S. Isaacson, A. Espay, S. Reyes, A. Formella, G. Ceresoli-Borroni (Detroit, USA)

Correlation Between Daily Vitamin Intake and Clinical Severity of Parkinson’s in Northeastern Mexico: An Exploratory Study

R. Trejo-Ayala, P. Ancer-Rodríguez, M. Herrera-López, K. Chapa-Ancer, J. Bermudes-Mendoza, A. Trejo-Ayala, R. Enriquez-Menchaca, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

Correlational Study of the Clinical Impression of Severity Index for Parkinson’s Disease (CISI-PD) with Functional Mobility Measures

ZE. Chan, KCY. Yong, KP. Lim, JP. Chua, TS. Toh, AH. Tan, SY. Lim (Subang Jaya, Malaysia)

Cross-Cultural Validation of the Hebrew version of The International Parkinson and Movement Disorder Society Non-Motor Rating Scale

VL. Livneh, A. Ezra, H. Lentschitzky, A. Socher, A. Thaler, A. Hilel, H. Shabtai, J. Zitser, G. Eshed, T. Shainer, P. Ponger, R. Alcalay, Y. Manor, V. Rozani, S. Luo, C. Goetz, G. Stebbins, P. Martin, T. Mestre, A. Ferro (Tel Aviv, Israel)

Deep brain stimulation improves levodopa-induced dyskinesias beyond medication reduction in Parkinson’s disease

C. Reyes, C. Martínez, J. Fonseca, F. Castro, A. Calderón, L. Reyes, C. Ramírez (Ciudad de México, Mexico)

Defining a Population-Based Cohort of Individuals with Probable REM Sleep Behavior Disorder

K. Eid, M. Flores-Torres, A. Hung, M. Schwarzschild, A. Ascherio, K. Bjornevik (Boston, USA)

Describing Factors Associated with Progression in Parkinson’s Disease: A Retrospective Chart Review

S. Rodrigo, T. Anderson, C. Goetz (Chicago, USA)

Detecting Parkinson’s Disease with Postural Sway via Single IMU and Machine Learning

F. Rashid, R. Fernandez-Rojas, S. Dal, M. Ghahramani (Canberra, Australia)

Determinants of Quality of Life According to Brain-first and Body-first in Patients with Parkinson’s Disease

XN. Liu, YL. Tang, XN. Liang, J. Wang (Shanghai, China)

Diagnostic Validity of PD Identification in a Neurologist-Certified National Drug Reimbursement Registry

V. Räty, T. Kuusimäki, T. Vahlberg, A-M. Tolppanen, V. Kaasinen (Turku, Finland)

Diet Quality and Nutrient Intake in Parkinson’s Disease: A Multicenter Study in Egypt

E. Abed (Cairo, Egypt)

Differences in Lewy body dementia in people from ethnic minorities: a systematic review of epidemiology, diagnosis, clinical features and imaging

S. Kalam, A. Zirra, J. Knight, L. Bishop, R. Fernando, C. Marshall, A. Noyce, R. Weil (London, United Kingdom)

Differential Oculomotor Patterns in Parkinson’s Disease and Multiple System Atrophy With Predominant Parkinsonism

Y. Liu, P. Tang (Xi'an, China)

Digital Kinematic Measures of Finger Tapping Detect Dose-Dependent Effects of Deep Brain Stimulation in Parkinson’s Disease

G. Acevedo, D. Vuddandam, A. Madamangalam, G. Kenworthy, C. Dehemptinne, J. Cagle, J. Wong (Gainesville, USA)

Digital Prediagnostic Mobility and Autonomic Trajectories in a Large Parkinson Disease Network

T. Jansen, A. Hare, R. Gilron (San Francisco, USA)

Digitizing PD Rating Scales Increases Reliability and Accessibility

Z. Yekutieli, Y. Yahalom, P. Lewitt (Tel-Aviv, Israel)

Disrupted Sleep and Daytime Sleepiness are Associated With Poorer Quality of Life in Advanced Parkinson’s Disease: ROSSINI Interim Results

I. Malaty, T. Henriksen, T. Mestre, R. Rodriguez, P. Schwingenschuh, M. Simu, L. Bergmann, S. Caughlin, M. Gopalkrishnan, P. Kukreja, M. O’Meara, J. Carlos Parra, M. Shah, W. Jost (Gainesville, USA)

Does Balance Mediate the Relationship Between Aerobic Capacity and Walking Endurance in Parkinson’s Disease?

C. Balasubramaniam, I. Wilkinson, J. Osborne, K. Flanagan, K. Mangipudi (Jacksonville, USA)

Does Fall-Related Activity Avoidance Differ between people with Parkinson’s disease versus Cognitively Unimpaired Controls?

M. Lindh-Rengifo, E. Franzén, M. Landers, E. Stomrud, M. Nilsson (Lund, Sweden)

Dopamine Agonist-Associated Dropped Head Syndrome in Parkinson’s Disease: A Case Series

L. Kovalchick, L. Qian, J. Theo, E. Krause (Austin, USA)

Driving Science to Address Early-Onset Parkinson’s Disease in U.S. Military Service Members

W. Hoffman, M. Salas, R. Izurieta, L. Saadatpour, J. Jacobson (JBSA-Lackland, USA)

Dual-Task Gait Costs are not Reduced by Immediate Repetition in Parkinson’s Disease

G. Koitla, P. Silva, H. Bernini, V. Silva, L. Aranha, D. Garcia, M. Santos, G. Santos, L. Santos, H. Santos, M. Piemonte (São Paulo, Brazil)

Dual-Task Gait Costs do not Increase Across Stages of Parkinson’s Disease

H. Bernini, G. Koitla, V. Silva, L. Santos, L. Aranha, D. Garcia, M. Santos, G. Santos, P. Silva, M. Piemonte (São Paulo, Brazil)

Dynamics of Motor Fluctuations and Medication Challenges in Parkinson’s Disease

O. Udomsirithamrong, R. Bhidayasiri, P. Panyakeaw (Bangkok, Thailand)

Dyskinesia-Hyperpyrexia Syndrome Mimicking a Generalized Seizure in Parkinson’s Disease

B. Kim, D. Jung, I. Song (Seoul, Republic of Korea)

Early longitudinal changes in non-motor symptoms and routine health checkup parameters around the emergence of prodromal features of Lewy body disease

D. Tamakoshi, K. Hiraga, T. Fukushima, Y. Saito, K. Fuse, T. Uematsu, T. Tsuboi, M. Sato, M. Yamamoto, H. Shimizu, M. Wakai, M. Katsuno (Nagoya, Japan)

Early Use of a Conversational Assistant to Interpret Wearable and Patient-Reported Data in Parkinson Disease

B. Hood, S. Shaffer, A. Hare, R. Gilron (San Francisco, USA)

Early-Onset Parkinson’s Disease with Early Peak-Dose Dyskinesia: A Case Report

VD. Tkachenko, MZ. Makoeva, MR. Portnova, AV. Nikitina (Moscow, Russian Federation)

Early-Onset Parkinson’s Disease Is Associated With Higher Utilization of Deep Brain Stimulation: Real-World Data From a Tertiary Movement Disorders Clinic

M. Arbeu Reyes, M. Rodríguez Violante, A. Cervantes Arriaga (Ciudad de México, Mexico)

Ecological Momentary Assessment Monitoring Captures Motor Fluctuation Improvement after DBS in Parkinson’s Disease

L. Drescher, J. Schikora, L. Feldmann, V. Witzig, P. Nonella, G. Brandt, GH. Schneider, J. Habets, A. Kühn (Berlin, Germany)

Effect of Random Training–Test Splits on Radiomic Classification of Parkinson’s Disease from T1-Weighted MRI in Machine Learning

S. Mehta, S. Batebi, G. Dumkrieger (Scottsdale, USA)

Effectiveness aNd use of fosleVOdopa-foscarbidopa in advanced Parkinson disease in real Life setting in France (ENVOL study): interim analysis

O. Colin, A. Marques, S. Montaut, D. Gueguen, MS. Behier, F. Ory Magne (Brive-la-Gaillarde, France)

Effects of LSVT BIG on Balance Dysfunction in Parkinson’s Disease and Its Underlying Cortical Regulatory Mechanisms Using fNIRS

X. Zha, P. Liu, J. Wu (Tianjin, China)

Electronic Health Record Integration Improves Markerless 3D Gait-Based Prediction of Parkinson’s Disease Motor Symptom Severity

L. Lim, K. Kim, Y. Wen, S. Lyu, Y. Shi, K. Mitchell, T. Dunn (Durham, USA)

Electrophysiological Tremor Analysis In Tremor-Dominant And Postural Instability And Gait Difficulty Phenotypes Of Parkinson’s Disease

L. Truong, H. Vu, Y. Vu, Y. Nguyen, L. Nguyen (Hanoi, Viet Nam)

Endogenous reproductive factors and risk of Parkinson’s disease in women: a systematic review and meta-analysis of observational studies

T. Ntetsika, E. Papathoma, T. Soumala, I. Markaki (Stockholm, Sweden)

Environmental Risk Factor Co-Exposure as Drivers of Parkinson’s Disease Development: A Scoping Review

A. Mcnamara, K. Daminato, L. Collins-Praino (Adelaide, Australia)

Epidemiology of Parkinson’s Disease and Parkinsonism in Kazakhstan from 2015 to 2024 based on National Health Data

ZH. Myrzayev, G. Saidakhmetova, B. Abdenov, M. Zholdybayeva, A. Muratbaikyzy, G. Mussagaliyeva, CH. Shashkin, R. Kaiyrzhanov (Almaty, Kazakhstan)

Establishing the Ukrainian Parkinson’s Disease Cohort within GP2: Early Results from the UPGRADE-PD Initiative

S. Bandrivska, H. Houlden, F. Magrinelli, A. Kolodii, V. Bashynska, I. Halushko, Y. Tsyoma, A. Bondarieva, A. Shevchenko, R. Svistilnik, O. Borysenko, O. Kripchak, L. Maksymova, R. Nasalyk, S. Shkrobot, I. Khubetova, A. Cherkez, P. Marushchenko, T. Slobodin (London, United Kingdom)

Evaluating Environmental, Cognitive and Psychiatric Factors in Pakistani PD patients: London Pakistan Parkinson`s Project (LP-3) Pilot Findings

F. Durrani, Z. Munawar, A. Khan, B. Khan, S. Hamdani, Z. Haq, M. Khan, W. Hafeez, A. Noyce, S. Waris (London, United Kingdom)

Exploring “sense of muscle contraction” during gluteus maximus training in Parkinson’s disease: a preliminary EMG perception study

J. Ogawa, K. Kakegawa, Y. Sotome, T. Matsuda (Ginza, Chuo-ku, Japan)

Exploring a Milestone-Based Approach as an Outcome Measure for Disease-Modifying Parkinson Disease Trials

C. Gonzalez-Robles, M. Burnell, A. Schrag, R. Weil, G. Mills, ML. Zeissler, J. Carpenter, S. Gandhi, C. Carroll, T. Foltynie (London, United Kingdom)

Exploring Demographic Correlates of Diagnostic Interval of Parkinson’s Disease

M. Bienen, O. Biggs-Rodriguez, P. Coss, S. Horn, L. Saadatpour, K. Ghosh-Galvelis, M. Dini, D. Petrosyan, E. Vaou, T. Pd Generation (San Antonio, USA)

Face Pareidolia in the East London Parkinson’s Disease Project

E. Camboe, KC. Dey, A. Zirra, S. Waters, E. Bhadra, R. Laban, B. Huxford, C. Simonet, C. Budu, DA. Gallagher, V. Azoidou, T. Boyle, C. Cooper, AJ. Noyce (London, United Kingdom)

Feasibility of the ActivPARK Study – Longitudinal Assessment of Physical Activity in People with Parkinson’s Disease

E. Franzén, L. Sandberg, M. Nilsson, F. Bergquist, G. Johansson, S. Guidetti, M. Hagströmer, EL. Jansson, D. Conradsson, G. Faxen Irving, S. Ljungblom, F. Albrecht, C. Joseph (Stockholm, Sweden)

Feasibility study of a portable medical device, the Neuromotor pen, as a screening tool for Parkinson’s disease in a rural northern Tanzania

I. Terry, T. Neal, R. Haggie, W. Eliamini, S. Linus, M. Dekker, S. Urasa, D. Mushi, R. Zietsma, D. Bramwell, C. Papasavvas, C. Nye, R. Walker, C. Dotchin (Newcastle, United Kingdom)

Fracture Burden and Health-Related Quality of Life in Older Adults with Parkinson’s Disease in Rural India: A Community-Based Study

B. Kuanar, D. Panda (Bhubaneswar, India)

Genetic risk factors reduce the risk of diabetes mellitus in Parkinsons disease

EK. Tan, S. Chan, B. Tan, L. Tan, C. Chan (Singapore, Singapore)

Genomic Insights into Parkinson’s Disease: LARGE-PD and PD GENEration Collaboration in El Salvador

S. Peña Martínez, T. Ascencio, R. de León, I. Mata (SS, El Salvador)

Global and Turkish Comorbidity Profiles in Parkinson’s Disease: The ANPAR Cohort and a Systematic Review

T. Abali, I. Koker, Z. özdamar, R. Yilmaz, MC. Akbostancı (Ankara, Turkey)

Global Performance Patterns in the MDS-UPDRS Motor Certification Program: A five-year Analysis

C. Falup-Pecurariu, C. Akbostanci, E. Bayram, I. Estrada-Bellmann, J. Ma, T. Mestre, I. Murasan, O. Ojo, P. Pal, M. Qamar, F. Rodriguez-Porcel, A. Sanchez Ferro (Brasov, Romania)

Grip strength and hand distress in de novo Parkinson´s disease: support for early rehabilitation

A. Szymanska, E. Franzén, L. Dahlin, S. Grigoriou, B. Lindholm (Stockholm, Sweden)

Head Trauma History and Motor Phenotype in Early Parkinson’s Disease

HL. Lee, SM. Choi (Gwangju, Republic of Korea)

High Step Marching Dyskinesia: A Case Series

N. Pulley, I. Bledsoe, P. Hoang (San Francisco, USA)

Hip and Elbow Joint Angle Characteristics of Patients with Parkinson’s Disease

D. Rasmiyani, A. Husni, E. Pasmanasari, A. Wati (Semarang, Indonesia)

How Common Is Central Pain in Parkinson’s Disease? A Systematic Review and Meta-Analysis

L. Gomes Pereira, K. Casali Vieira, C. David Antoniazzi, G. Trevisan (Santa Maria, Brazil)

Immigration status and Parkinson’s disease: a retrospective matched cohort study

A. Peral Quirós, N. Caballol Pons, P. Lombardo, A. Planas Ballvé, MI. Gómez-Ruiz, A. ávila Rivera (Sant Joan Despí, Spain)

Impact of Comorbidities on Clinical Outcomes and Socioeconomic Burden in Parkinson’s Disease: A 10-Year Nationwide Cohort Study

JS. Park, HT. Kim (Busan, Republic of Korea)

Impact of Multi-day Wearable Monitoring on Neurologists’ Assessment of Motor Fluctuations and Treatment Strategies in Parkinson’s Disease: A Real-World Study

M. Borrell-Pichot, L. Pérez-Carasol, A. Campolongo, B. Pascual-Sedano, R. Martínez-Fernández, JA. Aibar-Rodríguez, J. Kulisevsky, I. Aracli-Bolaños (Barcelona, Spain)

Impact of Variants in ADH1B and ALDH2 on Parkinson’s Disease in Japan

M. Kinoshita, H. Ohara, R. Sasaki, K. Tamura, M. Iyer, B. Vellingiri (Kyoto, Japan)

Implementation and Evaluation of a Pre-Clinic Questionnaire to Improve Data Capture and Consultation Efficiency in Parkinson’s Disease Clinics: A Multi-Centre Pilot Study

M. Qamar, H. Martin, J. Price, M. Parry (London, United Kingdom)

Incidence and Outcomes of Hip Fractures in Parkinsonism vs Non-Parkinson Population: A Systematic Review of the Literature

U. Saini (Chandigarh, India)

Influence of Disease Duration on Motor Progression in Parkinson’s Disease: A Longitudinal Cohort Study with Age at Onset Stratification and Sensitivity Analysis

N. Babu, S. Prasad, T. Nagaraj, S. Bhat, M. Bhardwaj, SS. Aramugham, K. Kumar, R. Mahale, P. Mailankody, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

Influence of disease stage upon real-world turning performance in people with Parkinson’s

C. Wilkinson, S. Del Din, C. Schlenstedt, C. Becker, J. Buekers, B. Caulfield, L. Delgado, J. Garcia-Aymerich, H. Gassner, A. Nieuwboer, J. Hausdorff, A. Mirelman, L. Rochester, W. Maetzler, A. Yarnall, L. Alcock (Newcastle-upon-Tyne, United Kingdom)

Integrated Digital Monitoring and Outpatient Clinical Care Management Program for Parkinson Disease

S. Shaffer, A. Hare, M. Anderson, M. Dauer, S. Grant, T. Jansen, J. Aldred, R. Gilron (Spokane, USA)

Interaction Between Physical and Cognitive Function That Determines ADL Improvement in Hospitalized Patients with Parkinson’s Disease: Implications for Individualized Rehabilitation Strategies

R. Nakagawa, M. Shiraishi, N. Takao, H. Matsumoto, Y. Yamano (Kawasaki City, Kanagawa Prefecture, Japan)

Interest in Clinical Trial Participation in Parkinson’s Disease: Insights from a Nationwide Registry

M. Peball, B. Heim, A. Djamshidian, F. Krismer, R. Katzenschlager, P. Schwingenschuh, W. Pirker, W. Poewe, K. Seppi (Innsbruck, Austria)

International validation of the Neuropsychiatric Fluctuations Scale in patients with Parkinson’s disease

I. Debove, C. Rodriguez-Blazquez, A. Zenger, A. Ayala, M. Bereau, S. Bostantjopoulou, KR. Chaudhuri, MA. Qamar, E. Cubo, B. Falkenburger, C. Falup-Pecurariu, MJ. Forjaz, MM. Kurtis, H. Reichmann, P. Krack, P. Martinez-Martin (Bern, Switzerland)

Interpretable AI for Quantitative Video-Based UPDRS Assessment of Hand Movements in Parkinson’s Disease

A. Irani, A. Mehrani, A. Soltani Mohammadi, K. Park, M. Mirian, R. Hosseini, H. Moradi, M. Mckeown (Tehran, Islamic Republic of Iran)

Investigating Smiling Asymmetries in Parkinson’s Disease through the Whistle–Smile Reflex

M. de Riggi, A. Martini, G. Paparella, D. Birreci, S. Aloisio, AS. Grandolfo, L. Angelini, D. Costa, L. Marsili, M. Bologna (Rome, Italy)

Investigating the Causal Relationship Between Tofu Intake and Parkinson’s Disease in the Asian Population Using Mendelian Randomization

X. Guo, R. Li (Xi'an, China)

Item – Level Drivers of Certification Failure in the MDS-UPDRS Motor Examination: A Five-Year Global Analysis

C. Falup-Pecurariu, C. Akbostanci, E. Bayram, I. Estrada-Bellmann, J. Ma, T. Mestre, I. Murasan, O. Ojo, P. Pal, M. Qamar, F. Rodriguez-Porcel, A. Sanchez Ferro (Brasov, Romania)

Knee Extensor Strength Is Associated with Torque Generation and Mobility in Parkinsonian Disorders

S. Komatsu, K. Sato, T. Ogawa, S. Hayasaka, K. Hatori, T. Hatano, T. Fujiwara (Urayasu, Japan)

Levodopa dosing regimen influences repetitive tongue force maintenance in Parkinson’s disease

S. Hayasaka, K. Hatori, K. Sato, T. Ogawa, T. Hatano, T. Fujiwara (Urayasu, Japan)

Levodopa Responsiveness and Motor Complication Trajectories in Parkinson’s Disease by α-Synuclein Seed Amplification Assay Status

H. Azizi, SM. Fereshtehnejad, R. Moqadam, M. Dadar, A. Siderowf, A. Dagher, Y. Zeighami (Montreal, Canada)

Levodopa-Induced Dyskinesia Predicts Falls, Fall-Related Injuries, and Their Consequences in Parkinson’s Disease: A Prospective PPMI Cohort Study

P. Pelicioni, L. Santos, S. Freitas, P. Nobrega-Sousa, K. Delbaere (Sao Paulo, Brazil)

Lifestyle Changes After Parkinson’s Disease Diagnosis: Associations with Age, Sex, Disease Duration, and Self-Perceived Quality of Life

J. Bestoso, R. Sanjinez, R. Huaiquil (Buenos Aires, Argentina)

Lifestyle Factors as Predictors of Progression in Parkinson’s Disease

X. Zhang, X. Chen, C. Christine, A. Hung, M. Schwarzschild, A. Ascherio, M. Flores Torres, K. Bjornevik (Boston, USA)

Linking Motor and Non-Motor Fluctuations in Parkinson’s Disease

A. Shaaban, A. Gaber, H. Salem, SH. Khater, A. Mansour (Cairo, Egypt)

Long-term evolution of deep brain stimulation parameters in Parkinson´s Disease: A 6-year analysis.

D. Oropeza-Velázquez, A. Morales-Velez, LA. Haro-Santillan, M. Velázquez-Vaquero, D. Oropeza-Canto, E. Peña-Andrade, Y. Tiburcio-Núñez, D. Blumenkron-Marroquín, A. Romero-Pérez, CE. Chávez-Donis (Puebla, Mexico)

Long-term exposure to fine particulate matter (PM2.5) is associated with earlier onset of Parkinson’s disease: a retrospective population-based cohort study

C. Santoro, M. Pesare, F. Catino, F. Castellana, N. Pilolli, A. Macerollo, G. Boero, R. Sardone (Taranto, Italy)

Longitudinal cognitive trajectories and predictors of dementia conversion in Parkinson’s disease

N. Sánchez-Lorenzo, K. Sánchez-Ramírez, M. Rocha-de-León, A. Beltrán-Torres, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante (Pachuca, Mexico)

Longitudinal Weight/BMI Trajectories and Their Clinical Impact on Parkinson’s Disease.

K. Sánchez-Ramírez, N. Sánchez-Lorenzo, A. Beltrán-Torres, M. Rocha-de-León, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

Magnitude of Non-Motor Symptoms Among People with Parkinson’s Disease in Rural and Urban Tanzania

B. Mushengezi, K. Okeng'O, R. Walker, M. Mng'Ong'O, E. Massawe, M. Dekker, N. Okubadejo, P. Adebayo, N. Fothergill-Misbah, Y. Okkaoglu, S. Urasa (Dar es Salaam, United Republic of Tanzania)

Mapping the Temporal Evolution of Non-Motor Symptoms in Parkinson’s Disease: Findings from 100 Outpatient Cases Using a Single-Page Temporal Template

F. Madathum Kuzhiyil, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

MDS Guidance Framework for Electronic Clinical Outcome Assessments: Updating Practices for Validation and Implementation

R. Fuller, M. Skorvanek, M. Monje, M. Tosin, T. Turner, S. Ali, A. Lane, A. Sanchez Ferro, T. Mestre (Princeton, USA)

MDS-UPDRS Part III Cannot Be Reliably Reduced for Prognostic Modeling in Early Parkinson’s Disease

M. Alam, G. Stebbins, T. Mestre, C. Goetz, S. Luo (Durham, USA)

Metabolic Syndrome and Disease Severity in Parkinson’s Disease: Association With Clinical Phenotype and Cerebral Small Vessel Disease

N. Başpınar, D. Türkoğlu, G. Yüksel (Istanbul, Turkey)

Metabolic Syndrome is not Associated with Parkinson’s Disease Severity, but Individual Metabolic Components May Be

TLD. Denicol, MPF. Felippe, GGA. Dal Alba, CMD. Dagostini, JSL. León, AH. Hilbig, CMR. Rieder (Porto Alegre, Brazil)

Military-related associations with Parkinson’s disease (PD) in the Millenium Cohort Study

S. Goldman, E. Richard, R. Rull, E. Boyko, K. Friedl, E. Hu, L. Liu, S. Boparai, N. Riedel, K. Comyns, E. Brown, C. Tanner (San Francisco, USA)

MLR–cerebellar network in body-first vs. brain-first PD: functional connectivity and clinical correlation with gait impairment

J. Jin, Z. Zong, S. Si, S. She, W. Wang, P. Pan (Wuhan, China)

Mobility Impairment And Balance Perception Discrepancy In Parkinson’s Disease

E. Isadora, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

Monopolar Sensing within the Globus Pallidus and the Relationship between Clinical Outcomes and Anatomy

M. Case, C. Zarns, A. Singh, R. Vigh, A. Holt-Becker, R. Raike, A. Ragothaman, J. Lee, G. Harker, L. Neilson, K. Burchiel, M. Mancini, D. Safarpour (Minneapolis, USA)

Mood Motor Interactions in Parkinson Disease Clinical Associations and Neurobiological Mechanisms

G. Mathew, T. Rogan, O. Nikas, M. Hayes (Boston, USA)

Motor and Non-Motor Symptoms Across Psychiatric Profiles in Parkinson’s: A Cluster Analysis

R. Trejo-Ayala, H. Trujillo-Guerra, R. Enriquez-Menchaca, A. Trejo-Ayala, B. Chávez-Luévanos, X. Ortiz-Jiménez, I. Estrada-Bellmann (Monterrey, Mexico)

Motor Frailty Index (MFI) as an Early Predictor of Functional Progression in Parkinson’s Disease: A Longitudinal Analysis

O. Esquivel-Zapata, M. Velasco -Delgado, A. Beltrán-Torres, N. Sánchez-Lorenzo, C. Abad-Tinajero, D. Nafate-Wences, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

Multidimensional Motor Dysfunction in Early Parkinsons Disease With Turning Velocity as a Sensitive Staging Biomarker

P. Liu, J. Wu (Tianjin, China)

Multilingual Smartphone Application for Objective Motor Assessment in Parkinson Disease: Cross-Sectional Clinical Validation Study

B. Biswas, S. Pal, K. Das, D. Santra, D. Mukherjee, R. Gayen, H. Kumar, S. Choudhury (Kolkata, India)

Multimodal Elastography-Assisted Quantitative Evaluation Tool for Diagnosing Rigidity in Parkinson’s Disease

J. Zhao, S. Ma, Z. Wan, C. Shi (Beijing, China)

Multimodal Gait Analysis Using Video Pose Estimation Deep Learning and Walkway Parameters: Parkinsonism Detection and Phenotyping

YS. Kim, JH. Yoon, RW. Park, DG. Park (Suwon, Republic of Korea)

Nation-wide Slovak epidemiological study of movement disorders in Roma population: protocol and initial results

M. Skorvanek, A. Belak, J. Necpal, M. Ferenc, M. Giertlova, L. Gurcik, V. Han, S. Jaselska, G. Kalafusova, M. Krauz, K. Kulcsarova, A. Lackova, J. Mankos, Z. Matiskova, S. Orkuty, M. Ostrozovicova, J. Papikova, O. Shabatiuk, L. Trckova, D. Fricova (Kosice, Slovakia)

Nationwide Prevalence of Parkinson’s Disease in Slovakia: A Municipality-Level Analysis

M. Skorvanek, Z. Kosutzka, I. Berta (Košice, Slovakia)

Neurofilament Light Chain as a Prognostic Marker of Motor Progression in Parkinson’s Disease: A Systematic Review

M. Sabharwal, D. Dash, A. Elavarasi, (London, Canada)

Neuronal aSynuclein Disease Integrated Staging System (NSD-ISS) Reveals Clinically Meaningful Functional Progression and Quality-of-Life Impact in Parkinson’s Disease

DA. Olszewska, D. Ghosh, S. Luo, C. Marras (Cork, Ireland)

Normative Data for the IDEA Dementia Screen in Healthy Older Adults and People with Parkinson’s Disease in Ethiopia: A Comparative Cross Sectional Study

S. Gugssa, H. Kiflu, Y. Okkaoglu, G. Mengistu (Addis Ababa, Ethiopia)

Objective Parkinson’s Diagnosis Using a Novel Accelerometer Assessment and Machine Learning

L. Jurcaga, E. Amigo, J. Oyaga-Orus, S. Aldea-Campillo, J. Marín-Lahoz, M. Vallejo (Edinburgh, United Kingdom)

Occupational Pesticide Exposure, Personal Protective Equipment, and Parkinson’s Disease: An Observational Study from the PPMI Cohort

B. Gonzalez-Bedolla, F. Luna-Rangel, S. Robles-Bernal, E. Santiago-Delacruz, D. Rebolledo-Garcia (Monterrey, Mexico)

Occupational Solvent Exposure and Parkinson’s Disease: An Observational Study in PPMI Online

F. Luna-Rangel, H. Martinez, O. Gutierrez-Treviño, C. Armengol-Garcia, J. Luna, B. Perez Martinez, J. Figueroa-Sanchez (San Pedro, Mexico)

Olfactory Dysfunction in Parkinson’s Disease: A Single-Center Study Using the Alcohol Sniff Test

S. Marisdina, U. Manurung (Palembang, Indonesia)

Online Assessments Measure Motor and Cognitive Progression in People with and without Parkinson’s Disease

E. Brown, X. Chen, P. Gonzalez Latapi, D. Weintraub, C. Marras, N. Pavese, L. Chahine, W. Poewe, R. Dobkin, K. Chou, E. Tolosa, A. Noyce, C. Stanley, T. Tropea, L. Racelo, M. Korell, K. Marek, C. Tanner (San Francisco, USA)

Optimizing Identification of Hyposmia for Parkinson’s Disease Risk Screening: Results from the Healthy Brain Aging Study

C. Theyer, S. Leiter, CG. Horlings, I. Egner, F. Krismer, S. Meyer, A. Noyce, E. Tolosa, A. Garrido, D. Pilco-Janeta, S. Ghosh, K. Rege, R. Krüger, M. Marti, V. Satagopam, B. Mollenhauer, C. Trenkwalder, K. Seppi, W. Poewe, P. Mahlknecht (Innsbruck, Austria)

Parkinson’s Disease and Osteoporosis Comorbidity: A Bibliometric Analysis and Exploration of Mechanistic Pathways and Key Genes

L. Xiao, J. Fan, Y. Wu, K. Liao, L. Zhuang (Guangzhou, China)

Parkinson’s Disease Duration at Total Knee Arthroplasty and 5-Year Vascular and Periprosthetic Outcomes: A Nationwide Matched Cohort Study

D. Kwon, H. Park (Seoul, Republic of Korea)

Passive Lumbar Accelerometry Reveals Motor and Behavioral Signatures Associated with High Risk for Parkinson’s Disease

A. Ziv, R. Vaknin Greenblatt, L. Yahimovich, Y. Lachberg, A. Thaler, JM. Hausdorff, A. Mirelman (Tel Aviv, Israel)

Patient perspectives on meaningful symptoms and disease progression in Parkinson’s Disease (PD): Interim findings from the Patient Endpoint Preference Project (PEPP)

V. Di Foggia, A. Noyce, E. Shelton, J. Mammen, F. de Renzis, A. Hursey, N. Wickramasekera, D. Rowen, M. Wilson, D. Magalhaes, J. Holenz, G. Harrison-Jones (Coronado, Portugal)

Patient self-rated Improvements with Opicapone: From randomized trials to Phase IV studies in fluctuating Parkinson’s Disease

H. C Brigas, C. Carroll, E. Freire, M. Pötter-Nerger, A. S. Morgadinho, B. Belvisi, D. Ramos, B. Fidalgo Dias, J. Holenz, J. J Ferreira (Newcastle, United Kingdom)

Perceptions and knowledge about Parkinson’s disease fluctuations among patients and caregivers: insights from a qualitative focus group

J. Romero Muñoz, J. Herreros, C. Soria Poveda, I. Santamaría Rodríguez (Madrid, Spain)

Performance of the functional staging of Parkinson’s disease using the Neuronal aSynuclein Disease Integrated Staging System (NSD-ISS) in the Critical Path for Parkinson’s (CPP) Integrated Parkinson’s Database

DA. Olszewska, D. Ghosh, S. Luo, C. Marras (Cork, Ireland)

Pesticide Exposure and Motor Severity in Parkinson’s Disease in a Mexican Population: A Retrospective Longitudinal Cohort Study

J. Espinoza-Solares, A. Tapia, L. Cortés, J. López-Moreno, A. Cervantes-Arriaga, M. Rodriguez-Violante (Ciudad de México, Mexico)

Pesticide Exposure and Smoking in Parkinson’s Disease in Kyrgyzstan: A Case–Control Study

A. Kubanychbekova, A. Ismailova, E. Zhunusova, S. Kyialbekova, A. Abdumalikova, C. Shambetova (Bishkek, Kyrgyzstan)

Physical Activity is Associated with Attenuated Motor and Cognitive Progression in Parkinson’s Disease

DW. Ryu, KR. Duque, J. Abanto, L. Marsili, NC. Paredes, AH. Gorriti, H. Deraz, E. Hill, A. Duker, AJ. Espay (Seoul, Republic of Korea)

Pilot feasibility study of home-based assessment of aspiration risk among people with Parkinson’s disease in rural northern Tanzania

R. Haggie, T. Neal, I. Terry, W. Eliamini, S. Linus, S. Ally, C. Nye, M. Dekker, S. Urasa, D. Mushi, R. Walker, C. Dotchin (Newcastle upon Tyne, United Kingdom)

Plasma Exchange and Reduced Parkinson’s Disease Diagnosis: A Nationwide Sequence Symmetry Analysis

S. Ueno, T. Saito, S. Nojiri, M. Nagao, Y. Nishizaki, M. Ishijima, T. Hatano (Bunkyo-ku, Japan)

Predicting Levodopa Responsiveness in Early Parkinson’s Disease Using Neural Perturbation Inference-Based Effective Connectivity

G. Xing, R. Siming (Guang Zhou, China)

Predictors of Parkinson’s Disease Phenoconversion in Non-manifesting LRRK2 Carriers

JH. Ng, X. Deng, EK. Tan (Singapore, Singapore)

Predictors of Severity of Psychosis in Parkinson’s Disease: A 3-year longitudinal cohort study

R. Sharma, J. Flanigan, B. Shah, J. Patrie (Charlottesville, USA)

Pregnancy and Breastfeeding in Early-Onset Parkinson’s Disease:Therapeutic Challenges of Levodopa Monotherapy.A case Report.

K. Salinas-Barboza, J. Altamirano, L. Salinas-Yañez, D. Avecilla-Bonilla (CDMX, Mexico)

Prevalence and associated factors of sarcopenia among Thai patients with ambulatory Parkinson’s disease

J. Intum, P. Lolekha, K. Chupisanyarote (Khlong Luang, Thailand)

Prevalence and Profile of Non-Motor Symptoms in Parkinson’s Disease in the Uzbek Population Assessed with the MDS-NMS Scale

D. Daminov (Tashkent, Uzbekistan)

Prevalence and Socio-Demographic Profile of Parkinson’s Disease in Rural Tanzania

S. Urasa, M. Dekker, J. Nyonyi, W. Howlett, D. Mushi, G. Lyimo, G. Kapanda, J. Rogathi, A. Makundi, N. Fothergill-Misbah, J. Nsengimana, Y. Okkaoglu, C. Dotchin, R. Morton, R. Walker (Moshi, United Republic of Tanzania)

Prevalence of drooling in Parkinson’s disease: a multi-center observational study

M. Iijima, R. Morimoto, K. Suzuki, T. Osada, S. Nogawa, Y. Okuma (Tochigi, Japan)

Prevalence of Parkinson’s Disease in the South Tongu District of Ghana and Projections of Current and Future Disease Burden (2026 – 2040)

M. Cham, E. Deh, D. Adanfo, V. Obese, R. Morton, R. Cilia, R. Odikro, E. Agbenyegah, E. Ame-Bruce, N. Fothergill-Misbah, O. Ojo, A. Akpalu, C. Dotchin, F. Baiden, N. Okubadejo, R. Walker (Sogakope, Ghana)

Probable RBD and Anxiety in Early Parkinson’s Disease Predict Subsequent Functionally Disabling Medication-Refractory Tremor

D. Ledingham, S. Sathyanarayana, R. Iredale, C. Stewart, V. Foster, D. Galley, M. Baker, N. Pavese (Newcastle Upon Tyne, United Kingdom)

Prosodic speech variability is associated with speech-related stigma in Parkinson’s disease

H. Jergas, T. Tienkamp, T. Thies, V. Stopic, G. Fink, D. Mücke, M. Barbe, A. Sauerbier (Cologne, Germany)

Proteomics Reveals Sex- and Age-of-onset-Stratified Immune Dysregulations in Parkinson’s Disease

X. Lu, J. Zhang, X. Cheng, J. Cheng, C. Ke, C. Liu, C. Mao (Suzhou, China)

Quadriceps Femoris and Gastrocnemius Muscle Activation Patterns during Gait in Patients with Parkinsons Disease Using Surface Electromyography

F. Fianurrachmania, E. Pasmanasari, R. Ardhini, J. Hartono (Semarang, Indonesia)

Quantitative Analysis of Oculomotor Abnormalities in Parkinson’s Disease

Y. Liu, P. Tang (Xi'an, China)

Quantitative Analysis of the DESH in Normal Pressure Hydrocephalus and Parkinson’s Disease

N. Takemura, T. Tsunemi, S. Niiyama, S. Yamada, C. Iseki, Y. Ohta, T. Hatano (Bunkyo-ku, Japan)

Quantitative Assessment of Turning Kinematics and its Association with Parkinson’s Disease Severity

G. Reinking, N. Meier, E. Lee (Irvine, USA)

Rates Of Phenoconvertion And Progression To Functionally Meaningful Impairment In NSD Stage 2B Participants: PPMI cohort

T. Simuni, C. Coffey, M. Brumm, C. Choi, R. Schneider, A. Siderowf, C. Tanner, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, C. Allen-Savietta, B. Wendelberger, A. Crawford, T. Tropea, K. Fabrizio, K. Marek (Iowa City, USA)

Re-evaluating Olfactory Testing and Cardiac 123I-MIBG Scintigraphy in the MDS Clinical Diagnostic Criteria for Parkinson’s Disease

T. Nukariya, M. Seki, T. Osada, J. Ebina, K. Suzuki, R. Sengoku, T. Hatano, H. Murakami, K. Sakuishi, M. Shiraishi, Y. Shimo, H. Terashi, H. Nagayama, H. Nakajima, K. Takahashi, S. Nogawa, Y. Okuma, F. Yoshii, M. Iijima, N. Hattori (Chiba, Japan)

Real-life accelerometer-based detection of DBS effects on tremor and dyskinesia in Parkinson’s disease, trained with ecological momentary assessments

J. Habets, V. Mathiopoulou, L. Drescher, A. Ben Janet, A. Buchwald, L. Muessig, J. Kaplan, A. Memarpouri, J. Vivien, L. Feldmann, G. Brandt, A. Kühn (Berlin, Germany)

Regional landscape of Parkinson’s disease: An update from the NeuRA Natural History of Parkinson’s Study

W. Liu, M. Li, R. Mackinnon, S. Geara, S. Lush, S. Rowe, C. Sue (Randwick, Australia)

Remote Digital Deployment of a Validated Psychosis Screener in Parkinson’s Disease: Real-World Feasibility and Screening Yield

A. Hare, S. Shaffer, B. Hood, R. Gilron (San Francisco, USA)

Remote Longitudinal Follow-up of Participants in the Parkinson’s Progression Markers Initiative (PPMI)

C. Tanner, C. Meng, E. Brown, D. Paredes, P. Ranola, G. Windheim, E. Trinh, K. Comyns, J. Ricci, C. Destro, R. Tandon, K. Geisler, A. Siderowf, T. Simuni, K. Marek (San Francisco, USA)

Retrieval-Augmented Generation (RAG) Chatbot for Parkinson’s Disease Patient Education and AI-Assisted Clinical Pre-Assessment

H. Ng, T. Mi, L. Guo, J. Gao, M. Grundy, E. Sierra, J. Wang, M. Mckeown (Vancouver, Canada)

Revisiting the Association between Estrogen Exposure and Parkinson’s Disease: A Fox Insight Analysis

S. Dharmadhikari, V. Dumoulin, S. Karim, M. Afshari (Chicago, USA)

Risk factors associated with Parkinson’s disease in the DRC (Case of the Initiative Plus Hospital Center, Kinshasa)

P. Kiatoko, R. Fure (KINSHASA, The Democratic Republic of the Congo)

Risk of Deep Venous Thrombosis in Patients With Parkinson’s Disease: A Meta‑Analysis of Observational Studies

V. Byroju, J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)

Saccadic Hypometria as a Biomarker of Longitudinal Change in MDS-UPDRS Part II and Axial Motor Subscores: Results from the Multicenter PALOMA Trial

A. Benesh, E. Raveh, E. Ben Ami, MSH. Tosin (Tel Aviv, Israel)

Seeing the Full Picture: How Subjective and Objective Data Capture the Daily Impact of Fluctuations in Parkinson’s disease.

J. Pagonabarraga, F. Escamilla-Sevilla, B. La Casa-Fages, N. Lopez-Ariztegui, J. Ruiz-Martinez, R. Garcia-Ramos, J. Infante, P. Mir, O. de Fabregues, F. Valldeoriola, Y. Compta (Granada, Spain)

Segment-Level Gait Dynamics Reveal Parkinsonian Motor Signatures in Fall-Prone Older Adults Using Multi-Channel Time–Frequency Deep Learning

B. Kim, C. Youm, J. Hwang, M. Kim, S. Cheon (Busan, Republic of Korea)

Sensor-Derived Gait Patterns Predict Motor Progression in Parkinson’s Disease Beyond Baseline Dopamine Transporter Imaging

H. Park, C. Youm, B. Kim, J. Hwang, M. Kim, S. Cheon, Y. Jeong, B. Jin (Busan, Republic of Korea)

Sex Differences in Motor and Nonmotor Symptoms of De Novo Parkinson Disease by Age Group

KY. Kwon, H. Lee, J. Yoon, G. Gye, G. Oh, J. You (Seoul, Republic of Korea)

Sex Differences in Prodromal Features of Parkinson’s Disease: Evidence from Large Multi-Centre Cohorts

M. Tan, Y. Zaplatnikov, K. Atterling-Brolin, S. Jónsdóttir, S. Schnell, R. Krüger, W. Poewe, P. Mahlknecht, E. Tolosa, M. Marti, V. Satagopam, C. Trenkwalder, L. Smith, C. Horlings, A. Noyce (Oslo, Norway)

Sex Differences in the Reported Prodromal Symptoms of Parkinson’s Disease (PD) in the Fox Insight Cohort

Z. Zullali, E. Trinh, G. Stebbins, E. Brown, K. Harrison, C. Meng, X. Chen, D. Paredes, K. Comyns, M. Korell, C M. Tanner (San Francisco, USA)

Sex Related Differences in Parkinsons Disease Motor and Non Motor Features Treatment Response and Quality of Life

R. Sanjinez, J. Bestoso (Buenos Aires, Argentina)

Sex-Specific Differences in Parkinson’s Disease: A Retrospective Analysis of over 10,000 Patients from the Paracelsus-Elena Hospital, a Specialized Movement Disorder Clinic in Germany

S. Weber, S. Schnell, H. Aust, C. Trenkwalder, B. Mollenhauer (Goettingen, Germany)

Sharing Personal Research Data in The PPMI Study: Participant Impressions After Disclosure

T. Tropea, M. Brumm, K. Brodkin, M. Miller, C. Destro, L. Heathers, H. Myers, R. Kurth, C. Pico, J. Carley, JM. Talarico, C. Stanley, Jr, M. Mcguire Kuhl, E. Flagg, T. Foroud, K. Marek (New Haven, USA)

Sleep Circadian Rhythms and Brain Disorders: A Large Prospective Cohort and Mendelian randomization Study

L. Li, Z. Zhong, L. Liu (shanghai, China)

Sleep Disturbances and Dyskinesia Burden in Parkinson’s Disease: Relevance for Motor Complication Management

V. Azoidou, E. Bhadra, E. Camboe, K. Dey, A. Zirra, K. Rowsell, C. Quah, C. Budu, T. Boyle, L. Pérez-Carbonell, D. Gallagher, J. Bestwick, A. Noyce, C. Simonet (London, United Kingdom)

Smartphone Video Derived Digital Motor Phenotypes of MDS UPDRS-Related Tasks via a Comprehensive Motor Function Test

N. Grammalidis, S. Dias, B. Alves, C. Giaralis, J. Zaras, K. Dimitropoulos, S. Bostantzopoulou-Kabouroglou, N. Del Campo, M. Kurtis, ML. Almarcha-Menargues, B. Falkenburger, T. Feige, N. Schnalke, A. Drif, M. Fabbri, S. Hadjidimitriou, L. Hadjileontiadis (Thermi, Greece)

Speech And Gait In Newly Diagnosed Parkinson’s Disease: Support For Early Rehabilitation

T. Yhlen, E. Franzen, M. Söderholm, S. Grigoriou, S. Whitling, B. Lindholm (Malmö, Sweden)

Speech and Voice Changes after Intensive Therapy in Parkinson’s Disease

L. Tadmor, O. Sella Weiss, Y. Ashkenazi, L. Yaakov, N. Stainer, T. Thies (Cologne, Germany)

Spiral Dx Real World Evaluation Of An Artificial Intelligence Algorithm For Tremor Detection From Hand Drawn Spirals Community Study Protocol Of A Population Screening Study For Parkinson Disease

MA. Hussain, P. Pankaj, S. Shreya, T. Radhakrishnan, A. R, D. R, D. Garg, A. Elavarasi, M. Tripathi, A. Garg, A. Upadhyay, D. Joshi, S. Kumaran, K. Prasad, AK. Srivastava, R. Rajan (New Delhi, India)

STEM-PD: An open-label phase I/II trial of transplanted human pluripotent stem cell-derived dopaminergic progenitor cells in Parkinson’s disease

G. Paul, H. Bjartmarz, A. Kirkeby, J. Nelander, R. Smith, S. Kayhanian, A. Evans, B. Harry, E. Cutting, S. Fazal, N. Lao-Kaim, T. van Vliet, I. Grubor, O. Hansson, P. Picchini, O. Lindvall, A. Björklund, H. Widner, M. Parmar, R. Barker (Lund, Sweden)

Subtle Behavioral Changes Observed by Knowledgeable Informants Up to Decades Before Parkinson’s Disease Diagnosis

E. Trinh, K. Harrison, E. Brown, M. Korell, C. Meng, K. Comyns, X. Chen, D. Paredes, L. Racelo, G. Stebbins, C. Tanner (San Francisco, USA)

Survival and Related Factors in Patients with Parkinson’s Disease : A Multicenter Prospective Cohort Study in China

S. Song, L. Xiang, Y. Liu, H. Pan, Y. Wu, X. Li, F. Luo, C. Wang, L. Lei, L. Yao, Y. Zhao, Z. Liu, Q. Sun, J. Guo, B. Tang, I. Wu, L. Yin, X. Zhou, Q. Xu (Changsha, China)

The “Guarda” (Tower) Drawing Test: A Novel Bedside Tool to Quantify Bradykinesia in Parkinson’s Disease

S. Celi Aguilar, F. Ramos, F. Echeverria, T. Arakaki, S. Rodriguez Quiroga, N. Garretto (Buenos Aires, Argentina)

The 360° Turn Test as a Single and Dual Task in people with Parkinson’s disease and cognitively unimpaired controls

M. Lindh-Rengifo, S. Fors, S. Palmqvist, E. Stomrud, N. Mattsson-Carlgren, M. Nilsson (Malmö, Sweden)

The Alternating Finger Tapping Test Poorly Predicts Real-World Daily Activity Performance in Parkinson’s Disease

P. Kaewsom, K. Horaruengdecha, P. Panyakaew (Bangkok, Thailand)

The association between Parkinson’s Disease and Diabetes Mellitus.

SJ. Foo, CS. Tan, H. Ng, K. Tay, S. Neo, W. Li, W. Au, Z. Xu, L. Tan (Singapore, Singapore)

The Effect of Scapular Dysfunction on Dynamic Balance in Patients with Parkinson’s Disease

G. Polat, A. Fil, Y. Salci, Aİ. Yalcin, S. Topuz, E. Turgut, G. Yalcin Cakmaklı, B. Elibol (Ankara, Turkey)

The Effects of War on Patients with Parkinson’s Disease

F. Hojjatipour, M. Salari, M. Etemadifar, K. Rezaei (Tehran, Islamic Republic of Iran)

The Green Parkinson’s Belt: An Ecological Study of Agricultural Regions Linked to Increased Disease Burden in Mexico

F. Luna-Rangel, B. Gonzalez-Bedolla, S. Robles-Bernal, E. Santiago-Delacruz, D. Rebolledo-Garcia (Monterrey, Mexico)

The influence of probable rapid eye movement sleep behavior disorder on PD-related motor and non-motor symptoms and multiple functional outcomes among Chinese community-dwelling elderly population

C. Han, P. Wang, J. Ma, P. Chan (Beijing, China)

The Parkinson’s Clinical Cohorts Collaborative (PC3) – A Novel Research Database for Parkinson’s Disease Research

A. Kuri, S. Waters, L. Smith, A. Thomson, R. Lawson, A. Macleod, M. Murray, M. Hu, A. Noyce (London, United Kingdom)

The Parkinson’s Impact Project: A Multimodal Longitudinal Study of Disease Development and Progression at the 23andMe Research Institute

M. Kmiecik, L. Norcliffe-Kaufmann, W. Xu, C. Weldon, V. Tran, A. Guan, M. Mcintyre, S. Aslibekyan (Palo Alto, USA)

The Prevalence of Parkinson’s Disease in Kilifi County, Kenya: A ‘Transforming Parkinson’s Care in Africa’ (TraPCAf) study

R. Morton, S. Mwamba, D. Nyabuto, S. Kariuki, A. Nyaguara, J. Nambafu, M. Atieno, D. Sokhi, M. Cham, S. Urasa, N. Okubadejo, O. Ojo, Y. Okkaoglu, C. Dotchin, N. Fothergill-Misbah, C. Newton, R. Walker (Newcastle Upon Tyne, United Kingdom)

The Spectrum of Praxis Impairments in Patients with Parkinson’s Disease

Z. Zalyalova, S. Munasipova, A. Volkova (Kazan, Russian Federation)

The Use of Digital Tools for Parkinson’s Phenotype Stratification to Improve Patients’ Selection for Advanced Therapies

T. Diven, S. Lane, K. Muhammed, L. Agley, R. Ellis, J. Pannicker, J. Osman-Farah, A. Macerollo (Liverpool, United Kingdom)

Three Years On: Outcomes of Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s disease from the Irish National DBS service

F. Ruggieri, M. Kelly, A. Gill, C. O'Keeffe, J. Inocentes, E. Reynolds, M. Garvey, N. Austin, M. Borsek, E. Pereira, T. Lynch, C. Faeron, C. Moran, R. Walsh (Dublin, Ireland)

Towards the detection of troublesome dyskinesia in Parkinson’s disease using wearable sensors

M. Ruben, C. Duval (Montréal, Canada)

Treatment Patterns and Time Between Therapies Among People with Parkinson’s Disease

M. Lubomski, A. Evans, R. Mackinnon, R. Rossiter, M. Falster, M. Kouhkamari, T. Suresh, A. Mikolaizak, J. Waern (St Leonards, Australia)

Treatment Patterns in Parkinson’s Disease in Kyrgyzstan: Evidence from a Kyrgyz PD Cohort

E. Zhunusova, S. Kyialbekova, C. Shambetova (Bishkek, Kyrgyzstan)

Tremor-onset Parkinson’s Disease: Does Leg Tremor Portend a Poor Prognosis?

D. Diaz, K. Mazinke, A. Rajput, A. Rajput, E. Noyes (Saskatoon, Canada)

Type 1 Diabetes and Risk of Parkinson’s Disease: A Nationwide Nested Case–Control Study

SH. Jeong, MH. Yu, N. Hong (Yongin-si, Republic of Korea)

Unveiling Oculomotor Phenotypes in Parkinson’s Disease: A Multidimensional Clustering Analysis

A. Rekik, E. Cherif, E. Mimouni, A. Mili, K. Jemai, I. Rekik, S. Ben Amor (Sousse, Tunisia)

Urate Levels and Risk of Parkinson’s Disease：A Two-Sample Mendelian Randomization Study

P. Tang, Y. Liu (Xi'an, China)

Use of Mucuna Pruriens (M. Pruriens) in People with Parkinson’s Disease (PwPD)

M. Bacigalupe, M. López, D. Merino (La Plata, Argentina)

Utility of Telephone Follow-up of PD Patients with Medication Adjustment

S. Neo, P. Yan, YC. Lee, K. Kae, W. Soo, R. Hoe, B. Koh, J. Oh, PL. Lau, A. Ng (Singapore, Singapore)

Validation of an Objective Parkinson’s Disease Digital Assessment Tool in Individuals with PD and Healthy Controls

N. Meier, O. Dimartino (Irvine, USA)

Validation of Augmented Reality–Based Speech Biomarkers for Objective Detection and Monitoring of Parkinson’s Disease and Atypical Parkinsonian Syndromes

M. Baran, W. Szecówka, J. Stępień, N. Bozetine, M. Dudek, J. Krzywdziak, M. Zbik, D. Hemmerling, M. Wojcik-Pedziwiatr, M. Rudzińska-Bar (Kraków, Poland)

Weight and Body Mass Index Changes in Parkinson’s Disease and Their Association with Disease Progression: A Two-Year Longitudinal Study

NF. Rahmy, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

What Non-Genetic Parkinson’s Disease Risk Factors are Africans Exposed To? A Scoping Review

J. Lee, R. Mwezi, R. Morton, N. Fothergill-Misbah, C. Dotchin, R. Walker (Arusha, United Republic of Tanzania)

« View all sessions from the 2026 International Congress.